HTR3A and Parkinson disease: Treatment with the 5-HT3R antagonists and antiemetics bemesetron, granisetron, or ondansetron improved catalepsy and bradykinesia in rodents,619,631 while ondansetron alleviated PD-related hyperalgesia in 6-OHDA-lesioned rats.637